Skip to main content

Table 3 Risk of bias assessed by NOS assessment tool

From: Double-carbapenem therapy in the treatment of multidrug resistant Gram-negative bacterial infections: a systematic review and meta-analysis

Author/YearDesignSelectionComparabilityOutcome
/Exposure
NOS
score
Pascale, 2017case-control study⁕⁕⁕⁕⁕⁕⁕7
Venugopalan, 2017cohort study⁕⁕⁕⁕⁕⁕7
Cancelli, 2018cohort study⁕⁕⁕⁕⁕⁕7